Seite - (000292) - in Biomedical Chemistry: Current Trends and Developments

Proceedings of the National Academy of Sciences, 108, 816-821. Benatar, M., & Wuu, J. (2012). Presymptomatic studies in ALS: rationale, challenges, and approach. Neurology, 79, 1732-1739. Carriedo, S. G., Yin, H. Z., & Weiss, J. H. (1996). Motor neurons are selectively vulnerable to AMPA/kainate receptor-mediated injury in vitro. Journal of Neuroscience, 16, 4069-4079. Corona, J. C., & Tapia, R. (2007). Ca2+-permeable AMPA receptors and intracellular Ca2+ determine motoneuron vulnerability in rat spinal cord in vivo. Neuropharmacology, 52, 1219- 1228. Corona, J. C., Tovar-y-Romo, L. B., & Tapia, R. (2007). Glutamate excitotoxicity and therapeutic targets for amyotrophic lateral sclerosis. Expert Opinion on Therapeutic Targets, 11, 1415- 1428. Cotman, C. W., & Monaghan, D. T. (1986). Anatomical organization of excitatory amino acid receptors and their properties. Advances in Experimental Medicine and Biology, 203, 237- 252. Debelleroche, J. S., & Bradford, H. F. (1977). Site of Origin of Transmitter Amino-Acids Released by Depolarization of Nerve-Terminals Invitro. Journal of neurochemistry, 29, 335-343. Gardoni, F., & Di Luca, M. (2006). New targets for pharmacological intervention in the glutamatergic synapse. European Journal of Pharmacology, 545, 2-10. Grosskreutz, J., Van Den Bosch, L., & Keller, B. U. (2010). Calcium dysregulation in amyotrophic lateral sclerosis. Cell Calcium, 47, 165-174. Hardingham, G. E., & Bading, H. (2010). Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders. Nature Reviews Neuroscience, 11, 682-696. Henley, J. M., Barker, E. A., & Glebov, O. O. (2011). Routes, destinations and delays: recent advances in AMPA receptor trafficking. Trends in Neurosciences, 34, 258-268. Hideyama, T., Yamashita, T., Aizawa, H., (2012). Profound downregulation of the RNA editing enzyme ADAR2 in ALS spinal motor neurons. Neurobiology of Disease, 45, 1121-1128. Hu, N. W., Ondrejcak, T., & Rowan, M. J. (2012). Glutamate receptors in preclinical research on Alzheimer’s disease: update on recent advances. Pharmacology Biochemistry and Behavior, 100, 855-862. Isaac, J. T., Ashby, M. C., & McBain, C. J. (2007). The role of the GluR2 subunit in AMPA receptor function and synaptic plasticity. Neuron, 54, 859-871. Kang, J. E., Lim, M. M., Bateman, R. J., (2009). Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle. Science, 326, 1005-1007. Keller, B. U., Hollmann, M., Heinemann, S., (1992). Calcium influx through subunits GluR1/GluR3 of kainate/AMPA receptor channels is regulated by cAMP dependent protein kinase. EMBO Journal, 11, 891-896. Kerchner, G. A., & Nicoll, R. A. (2008). Silent synapses and the emergence of a postsynaptic mechanism for LTP. Nature Reviews Neuroscience, 9, 813-825. Koutsilieri, E., & Riederer, P. (2007). Excitotoxicity and new antiglutamatergic strategies in Parkinson’s disease and Alzheimer’s disease. Parkinsonism & Related Disorders, 13(Suppl 3), S329-331. Lau, A., & Tymianski, M. (2010). Glutamate receptors, neurotoxicity and neurodegeneration. Pflugers Archiv, 460, 525-542.